| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918594 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
Compared to the 54 Gy/9 fractions regimen, dose-reduced regimen of 45.5Â Gy/7 fractions using HDR brachytherapy as monotherapy preliminarily showed an equivalent or lower incidence rate for acute and late toxicities without compromising the excellent PSA failure-free rate. Further studies with more patients and longer follow-up are warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yasuo Yoshioka, Koji Konishi, Osamu Suzuki, Yasutomo Nakai, Fumiaki Isohashi, Yuji Seo, Yuki Otani, Masahiko Koizumi, Ken Yoshida, Hideya Yamazaki, Norio Nonomura, Kazuhiko Ogawa,